A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Nanjing Leads Biolabs Co.,Ltd
Murdoch Childrens Research Institute
Peking University First Hospital
Peking University First Hospital
Peking University First Hospital
Andes Biotechnologies
Celgene
Traws Pharma, Inc.
Lixte Biotechnology Holdings, Inc.
L'Hospitalet de Llobregat
Danish University of Pharmaceutical Sciences
INSYS Therapeutics Inc